Your browser doesn't support javascript.
loading
Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021.
Hess, Lisa M; Krein, Peter M; Haldane, Diane; Han, Yimei; Sireci, Anthony N.
Affiliation
  • Hess LM; Eli Lilly and Company, Indianapolis, Indiana.
  • Krein PM; LOXO Oncology, a wholly-owned subsidiary of Eli Lilly and Company, Indianapolis, Indiana.
  • Haldane D; Eli Lilly and Company, Indianapolis, Indiana.
  • Han Y; Eli Lilly and Company, Indianapolis, Indiana.
  • Sireci AN; LOXO Oncology, a wholly-owned subsidiary of Eli Lilly and Company, Indianapolis, Indiana.
JTO Clin Res Rep ; 3(6): 100336, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35677681
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Country of publication: United States